Study identification

PURI

https://redirect.ema.europa.eu/resource/1000000112

EU PAS number

EUPAS1000000112

Study ID

1000000112

Official title and acronym

DARWIN EU® Overall survival in patients with locally advanced or metastatic non-small cell lung cancer treated with selected immunotherapies as first line of treatment

DARWIN EU® study

Yes

Study countries

France
Netherlands
Spain

Study description

Comparative Effectiveness Study

Study status

Ongoing
Research institution and networks

Institutions

Networks

Contact details

Talita Duarte-Salles

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of interim report, if expected

Planned:

Date of final study report

Planned:
Sources of funding
EMA
Study protocol
Initial protocol
English (884.56 KB - PDF)View document
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable